On Invalid Date, Maia Biotechnology (NYSEMKT: MAIA) reported Q4 2023 earnings per share (EPS) of -$0.41, up 13.89% year over year. Total Maia Biotechnology earnings for the quarter were -$6.26 million. In the same quarter last year, Maia Biotechnology's earnings per share (EPS) was -$0.36.
As of Q2 2024, Maia Biotechnology's earnings has grown year over year. Maia Biotechnology's earnings in the past year totalled -$19.77 million.
What is MAIA's earnings date?
Maia Biotechnology's earnings date is Invalid Date. Add MAIA to your watchlist to be reminded of MAIA's next earnings announcement.
What was MAIA's revenue last quarter?
On Invalid Date, Maia Biotechnology (NYSEMKT: MAIA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Maia Biotechnology's revenue was $0.00.
What was MAIA's revenue growth in the past year?
As of Q2 2024, Maia Biotechnology's revenue has grown null year over year. Maia Biotechnology's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.